Home › Funds › ACT Capital Partners, L.P. › CRVS

ACT Capital Partners, L.P. position in CRVS

CORVUS PHARMACEUTICALS INC · Health Care

ACT Capital Partners, L.P. reported holding 27,000 shares of CRVS (CORVUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$311K, representing 0.21% of its reported portfolio and ranking #41 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.

Latest position (Q3 2026)27.00K sh
Reported value held$311.04K
Portfolio Weight0.21%
First reportedQ3 2026
Last changeNew
Updated2026-11-07

Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR

How ACT Capital Partners, L.P.'s CRVS position evolved

ACT Capital Partners, L.P. first disclosed a stake in CRVS in Q3 2026 at 27,000 shares (US$311K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 27.00K $311.04K New

About CRVS and 13F data

CRVS (CORVUS PHARMACEUTICALS INC) is a Health Care company. 73 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), ADAMS STREET PARTNERS LLC (US$48.9M), Vivo Capital, LLC (US$41.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRVS

All CRVS fund holders →

FAQ

How long has ACT Capital Partners, L.P. held CRVS?

ACT Capital Partners, L.P. has disclosed CRVS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is ACT Capital Partners, L.P.'s current position in CRVS?

As of Q3 2026, ACT Capital Partners, L.P. holds 27.00K shares of CRVS (CORVUS PHARMACEUTICALS INC), valued at $311.04K, representing 0.21% of its reported portfolio and ranking #41.

Has ACT Capital Partners, L.P. been buying or selling CRVS?

In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in CRVS.

Which other funds hold CRVS?

Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, Vivo Capital, LLC, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.